Illinois has enacted a law that eases patient access to its medical cannabis program while adding product-safety rules, according to a release from the governor’s office on Gov. JB Pritzker’s June 12, 2026 signing of Senate Bill 3222. Under the law, every licensed dispensary may register as a medical cannabis dispensary, and physicians can certify patients’ qualifying conditions by telehealth.
Dispensaries may also offer curbside pickup and drive-through service, with priority for medical patients, and the qualifying conditions now include endometriosis and ovarian cysts. On the safeguards side, selling intoxicating hemp products to anyone under 21 is prohibited immediately, and those products will be regulated as cannabis from Nov. 12, 2026.
The release also says products must undergo testing and carry detailed labels, packaging cannot target minors or make health claims, and testing labs will be licensed rather than registered. Together, the provisions show how patient access and oversight can sit in the same statute.